Cargando…
AG490, a JAK2-specific inhibitor, downregulates the expression and activity of organic anion transporter-3
Human organic anion transporter-3 (hOAT3) is richly expressed in the kidney, where it plays critical roles in the secretion of clinically important drugs, including anti-viral therapeutics, anti-cancer drugs, antibiotics, antihypertensives, and anti-inflammatories. In the current study, we examined...
Autores principales: | Zhang, Jinghui, Liu, Chenchang, You, Guofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863619/ https://www.ncbi.nlm.nih.gov/pubmed/29487013 http://dx.doi.org/10.1016/j.jphs.2018.01.006 |
Ejemplares similares
-
Interaction of Anticancer Drugs with Human Organic Anion Transporter hOAT4
por: Liu, Chenchang, et al.
Publicado: (2019) -
Protein kinase C regulates organic anion transporter 1 through phosphorylating ubiquitin ligase Nedd4–2
por: Yu, Zhou, et al.
Publicado: (2021) -
Chloroquine and Hydroxychloroquine, as Proteasome Inhibitors, Upregulate the Expression and Activity of Organic Anion Transporter 3
por: Liang, Zhengxuan, et al.
Publicado: (2023) -
The JAK2/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro
por: Zhou, Ying, et al.
Publicado: (2020) -
JAK Inhibitors AG-490 and WHI-P154 Decrease
IFN-γ-Induced iNOS Expression and NO Production in Macrophages
por: Sareila, Outi, et al.
Publicado: (2006)